Rivastigmine in the treatment of Alzheimer's disease: an update
Clinical Interventions in Aging · 2007-03 · 2 (1) · 17-32
DOI: 10.2147/ciia.2007.2.1.17 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Interventions in Aging, 2007-03. Verfasst von Maria Luisa Onor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Morphological and Technological Sciences, UCO of Clinical Psychiatry, University of Trieste, Trieste, Italy. marialuisa.onor@…. Die Arbeit wurde bisher 140-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical, Morphological and Technological Sciences, UCO of Clinical Psychiatry, University of Trieste, Trieste, Italy. marialuisa.onor@libero.it
Zitieren
APA
Onor, M. L., Trevisiol, M., & Aguglia, E. (2007). Rivastigmine in the treatment of Alzheimer's disease: an update. Clinical Interventions in Aging, 2(1), 17-32. https://doi.org/10.2147/ciia.2007.2.1.17
Vancouver
Onor ML, Trevisiol M, Aguglia E. Rivastigmine in the treatment of Alzheimer's disease: an update. Clinical Interventions in Aging. 2007;2(1):17-32. doi:10.2147/ciia.2007.2.1.17
BibTeX
@article{Onor2007,
author = {Onor, Maria Luisa and Trevisiol, Marianna and Aguglia, Eugenio},
title = {Rivastigmine in the treatment of Alzheimer's disease: an update},
journal = {Clinical Interventions in Aging},
year = {2007},
volume = {2},
number = {1},
pages = {17--32},
doi = {10.2147/ciia.2007.2.1.17}
}
EUVIMED